These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 22123065)

  • 21. DNA vaccines for biodefense.
    Dupuy LC; Schmaljohn CS
    Expert Rev Vaccines; 2009 Dec; 8(12):1739-54. PubMed ID: 19943766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age of Bioterrorism: Are You Prepared? Review of Bioweapons and Their Clinical Presentation for Otolaryngologists.
    Zapanta PE; Ghorab S
    Otolaryngol Head Neck Surg; 2014 Aug; 151(2):208-14. PubMed ID: 24757076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Threats in bioterrorism. I: CDC category A agents.
    Darling RG; Catlett CL; Huebner KD; Jarrett DG
    Emerg Med Clin North Am; 2002 May; 20(2):273-309. PubMed ID: 12120480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bioterrorism].
    Sata T
    Nihon Hoigaku Zasshi; 2005 Oct; 59(2):119-25. PubMed ID: 16296383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of suspected cases of bioterrorism: a pediatric perspective.
    Patt HA; Feigin RD
    Pediatrics; 2002 Apr; 109(4):685-92. PubMed ID: 11927716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses.
    Zhu Z; Dimitrov AS; Chakraborti S; Dimitrova D; Xiao X; Broder CC; Dimitrov DS
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):57-66. PubMed ID: 16441209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological agents: weapons of warfare and bioterrorism.
    Broussard LA
    Mol Diagn; 2001 Dec; 6(4):323-33. PubMed ID: 11774197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant human polyclonal antibodies: A new class of therapeutic antibodies against viral infections.
    Bregenholt S; Jensen A; Lantto J; Hyldig S; Haurum JS
    Curr Pharm Des; 2006; 12(16):2007-15. PubMed ID: 16787244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioterrorism: class A agents and their potential presentations in immunocompromised patients.
    Richard JL; Grimes DE
    Clin J Oncol Nurs; 2008 Apr; 12(2):295-302. PubMed ID: 18390465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recombinant antibodies against bioweapons].
    Thullier P; Pelat T; Vidal D
    Med Sci (Paris); 2009 Dec; 25(12):1145-8. PubMed ID: 20035695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioterrorism: a new frontier for drug discovery and development.
    Shailubhai K
    IDrugs; 2003 Aug; 6(8):773-80. PubMed ID: 12917773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Germs employed as biological weapons].
    Meyer CG; May J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Sep; 37(9):538-46. PubMed ID: 12215940
    [No Abstract]   [Full Text] [Related]  

  • 33. [Contemporary control of biological warfare].
    Płusa T; Jahnz-Rózyk K
    Pol Merkur Lekarski; 2002 Mar; 12(69):173-7. PubMed ID: 12053581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zoonoses likely to be used in bioterrorism.
    Ryan CP
    Public Health Rep; 2008; 123(3):276-81. PubMed ID: 19006970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic options for diseases due to potential viral agents of bioterrorism.
    Bronze MS; Greenfield RA
    Curr Opin Investig Drugs; 2003 Feb; 4(2):172-8. PubMed ID: 12669378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines against biologic agents: uses and developments.
    Ales NC; Katial RK
    Respir Care Clin N Am; 2004 Mar; 10(1):123-46. PubMed ID: 15062232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid focused sequencing: a multiplexed assay for simultaneous detection and strain typing of Bacillus anthracis, Francisella tularensis, and Yersinia pestis.
    Turingan RS; Thomann HU; Zolotova A; Tan E; Selden RF
    PLoS One; 2013; 8(2):e56093. PubMed ID: 23418519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens,
    Tao P; Mahalingam M; Zhu J; Moayeri M; Kirtley ML; Fitts EC; Andersson JA; Lawrence WS; Leppla SH; Chopra AK; Rao VB
    Front Immunol; 2017; 8():687. PubMed ID: 28694806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The medical threat of biological weapons.
    Atlas RM
    Crit Rev Microbiol; 1998; 24(3):157-68. PubMed ID: 9800098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Raxibacumab.
    Mazumdar S
    MAbs; 2009; 1(6):531-8. PubMed ID: 20068396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.